Abstract
Reports have emerged of myocarditis and pericarditis predominantly after the second dose of the coronavirus disease messenger ribonucleic acid vaccine. We describe 13 patients aged 12-17 years who presented with chest pain within 1 week after their second dose of the Pfizer vaccine and were found to have elevated serum troponin levels and evidence of myopericarditis.
Keywords: COVID-19 vaccine; myocarditis.
Copyright © 2021 Elsevier Inc. All rights reserved.
MeSH terms
- Adolescent
- BNT162 Vaccine
- COVID-19 / epidemiology
- COVID-19 / prevention & control*
- COVID-19 Vaccines / adverse effects*
- Child
- Female
- Humans
- Incidence
- Male
- Myocarditis / epidemiology
- Myocarditis / etiology*
- Pandemics
- Pericarditis / epidemiology
- Pericarditis / etiology*
- Retrospective Studies
- SARS-CoV-2 / immunology*
- Vaccination / adverse effects*
- Vaccines, Synthetic / adverse effects*
- Washington / epidemiology
- mRNA Vaccines
Substances
- COVID-19 Vaccines
- Vaccines, Synthetic
- BNT162 Vaccine